Compounded tirzepatide online was widely available during the FDA-listed shortage of the medication (2022 to 2024) through licensed compounding pharmacies. After the FDA resolved the shortage and enforcement actions concluded, the legitimate pathway for large-scale online compounded tirzepatide narrowed significantly. Most online offerings from non-FDA-registered facilities now operate in a legally gray or non-compliant space, and the identity, potency, and sterility of those products cannot be reliably verified. If cost is the concern, LillyDirect direct-to-patient pricing and manufacturer savings cards on brand-name Mounjaro or Zepbound are usually the better path.
The Shortage Era Timeline
| Period | Status | What It Meant for Compounding |
|---|---|---|
| Dec 2022 – Oct 2024 | Tirzepatide on FDA Drug Shortage list | Licensed 503A and 503B compounding pharmacies could legally prepare tirzepatide under section 503A (patient-specific) or 503B (office-stock) |
| Oct 2024 | FDA declared shortage resolved | Compounding window closed; compounded product to be depleted on set timelines |
| Late 2024 – early 2025 | Litigation; shortage briefly reinstated | Pharmacies permitted continued compounding during appeals |
| 2025 onward | Shortage resolved; enforcement increasing | Legitimate compounding restricted to individual prescriptions with clinical justification; mass-market online compounding restricted |
Readers should check the FDA Drug Shortage Database for the current status before assuming access remains available.
Why Compounding Was Legally Available During the Shortage
US law (the FDCA, section 503A and 503B) allows compounding pharmacies to prepare drugs that are on the FDA’s drug-shortage list, so patients can still receive therapy. Once a drug is removed from the shortage list, this legal pathway narrows dramatically — compounding is generally only allowed if:
- The compounded product has a clinically significant difference from the commercial product (e.g., a patient needs a preservative-free version)
- The patient has documented allergy or intolerance to an inactive ingredient in the commercial product
- A licensed practitioner has issued an individual prescription with valid clinical rationale
Mass-market production of essentially the same drug, post-shortage, is typically not permissible under 503A or 503B rules.
Risks of Non-Regulated Online Compounded Tirzepatide
- Identity uncertainty: independent testing has found products labeled as one peptide containing another, at wrong concentrations, or with significant impurities.
- Sterility and pyrogens: injectable products require strict sterility controls; contaminated peptide injections have caused serious infections.
- Dose variability: reconstitution instructions online are often inconsistent; dosing errors can be severe with GLP-1 class drugs.
- Unverified ingredients: excipients, preservatives, and bacteriostatic water used in unofficial products vary and may not match what was tested for safety.
- No adverse event reporting: problems with non-regulated products do not flow into the FDA’s surveillance system.
- No recourse: if you are harmed, legal and medical support is limited.
Red Flags for Online Tirzepatide Sellers
- Questionnaire-only prescribing without a real clinician visit
- Heavy social media advertising, influencer promotion, or affiliate codes
- Cryptocurrency or international wire transfers as accepted payment
- Shipping from outside the US or through third-party freight forwarders
- No verifiable state pharmacy license
- No FDA 503B registration when offered at scale
- No certificate of analysis provided with each lot
- Claims of “research use only” alongside patient dosing instructions
- Prices dramatically lower than even legitimate LillyDirect self-pay rates
Legitimate Paths to Tirzepatide
1. Commercial Insurance + Manufacturer Savings Card
Most commercial plans cover Mounjaro for type 2 diabetes and some cover Zepbound for obesity. The Mounjaro and Zepbound savings cards can reduce copays substantially for commercially insured patients with coverage.
2. LillyDirect Direct-to-Patient
Eli Lilly launched LillyDirect with flat monthly cash prices for specific Zepbound dose strengths and later Mounjaro vials, aimed at self-pay patients. Prices have ranged around $349 to $499 per month depending on dose and product configuration. The program ships in cold-chain packaging from licensed mail-order pharmacies.
3. Patient Assistance
Lilly Cares provides free medication to qualifying uninsured or underinsured patients who meet income requirements.
4. Medicare and Medicaid
Medicare Part D excludes anti-obesity drugs by statute but covers Mounjaro for type 2 diabetes per plan formulary. State Medicaid coverage varies.
5. Alternative FDA-Approved Drugs
If tirzepatide access remains difficult, FDA-approved alternatives include:
- Ozempic (semaglutide) for type 2 diabetes
- Wegovy (semaglutide 2.4 mg) for obesity
- Trulicity (dulaglutide) for type 2 diabetes
- Victoza (liraglutide) for type 2 diabetes
- Saxenda (liraglutide) for obesity
See our related guides on Zepbound for diabetes and NovoCare Pharmacy Wegovy.
How to Vet a Compounding Pharmacy If You Must
- Confirm current state pharmacy license in the pharmacy’s home state
- Check FDA website for 503B outsourcing facility registration
- Search FDA warning letters for the pharmacy name
- Verify that a US-licensed physician is evaluating you (not just issuing prescriptions off a form)
- Ask for a certificate of analysis specific to the lot you receive
- Confirm the pharmacy ships in proper cold-chain packaging
- Keep your diabetes care team informed of what you are taking and the source
The Bottom Line
Compounded tirzepatide online was legal and widely available during the FDA shortage; it is now largely restricted outside of narrow clinical-exception compounding. Products still sold through non-regulated online marketplaces carry real safety risks and limited recourse. For most patients, LillyDirect direct-to-patient pricing, manufacturer savings cards, insurance coverage, or alternative FDA-approved GLP-1 drugs are safer and often comparably priced. Always loop in your clinician before acting on online offers.
